About In-vitro Diagnostics Instruments The global IVD instruments market is expected to grow at a steady rate during the forecast period. The factors like increasing older population, rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the rise in diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities and launches are expected to positively influence the market growth over the next few years. Technavio’s analysts forecast the global in-vitro diagnostics instruments market to grow at a CAGR of 9.73% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global in-vitro diagnostics instruments market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of IVD instruments. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global In-vitro Diagnostics Instruments Market 2016-2020, has been prepared based on an... Research Beam Model: Research Beam Product ID: 958304 2500 USD New
Global In-vitro Diagnostics Instruments Market 2016-2020
 
 

Global In-vitro Diagnostics Instruments Market 2016-2020

  • Category : Healthcare
  • Published On : November   2016
  • Pages : 101
  • Publisher : Technavio
 
 
 
About In-vitro Diagnostics Instruments

The global IVD instruments market is expected to grow at a steady rate during the forecast period. The factors like increasing older population, rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the rise in diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities and launches are expected to positively influence the market growth over the next few years.

Technavio’s analysts forecast the global in-vitro diagnostics instruments market to grow at a CAGR of 9.73% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global in-vitro diagnostics instruments market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of IVD instruments.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global In-vitro Diagnostics Instruments Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Abbott Laboratories
• Danaher
• Roche Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific

Other prominent vendors
• A&T
• A. Menarini Diagnostics
• Abaxis
• Abcam
• Accriva Diagnostics
• Acon Laboratories

• Affymetrix
• Ahram Biosystem
• ARKRAY
• AsuraGen
• Biocartis
• Bio-Rad Laboratories
• CellaVision
• Cepheid

• Chembio Diagnostic Systems
• Chembio Diagnostic Systems
• Clarity Diagnostics
• Corgenix
• DiagCor
• Drucker Diagnostics
• EKF Molecular Diagnostics
• Erba Diagnostics
• GREEN CROSS MEDIS
• Helena Laboratories
• Hologic
• HORIBA
• Instrumentation Laboratory
• i-Sens
• Landwind Medical
• Mindray
• Nihon Kohden
• Nipro Diagnostics
• Randox Laboratories
• Sekisui Medical
• Sienco
• Sinduri Biotec
• Snibe Diagnostics
• Stago
• Trivitron Healthcare

Market driver
• High demand for automation and integration of multiple processes driving new product development
• For a full, detailed list, view our report

Market challenge
• Reduction in profits for manufacturers due to the US medical device tax policies
• For a full, detailed list, view our report

Market trend
• Potential opportunities for physician office laboratories (POL)
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



Table of Contents
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Immunochemistry
• Clinical microbiology
• POCT
• SMBG
• Tissue diagnostics
• Molecular diagnostics
• Hematology
• Hemostasis
PART 07: Market segmentation by end-user
• Hospitals and diagnostic laboratories
• Home care
• Academic and research institutes
PART 08: Geographical segmentation
• IVD instruments market in Americas
• IVD instruments market in EMEA
• IVD instruments market in APAC
PART 09: Focus on emerging markets
PART 10: Market drivers
• Strategic initiatives by vendors
• Demand for personalized medicine
• Growing focus on diagnosing life-threatening conditions boosting POCT segment
• High demand for automation and integration of multiple processes driving new product development
PART 11: Impact of drivers
PART 12: Market challenges
• Strained laboratory budgets and lowering reimbursement affecting instrument sales
• Industry consolidation posing threat to new entrants
• Reduction in profits of manufacturers due to the US medical device tax policies
• Limitations of closed systems in IVD testing
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Potential opportunities for physician office laboratories (POL)
• Leasing of IVD instruments
• Increase in M&A
• Advances in technology
PART 15: Vendor landscape
• Competitive scenario
PART 16: Key vendor analysis
• Abbott Laboratories
• Danaher
• Roche Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific
• Key companies to watch
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio0
List of Exhibits
Exhibit 01: IVD instruments segments analysis 2015
Exhibit 02: Product offerings
Exhibit 03: Global IVD instruments market: Overview
Exhibit 04: Global IVD instruments market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Market overview of immunochemistry instruments
Exhibit 07: Classification of immunochemistry market
Exhibit 08: Global immunochemistry instruments market 2015-2020 ($ billions)
Exhibit 09: Immunochemistry metrics analysis
Exhibit 10: Market overview of clinical microbiology instruments
Exhibit 11: Global clinical microbiology instruments market 2015-2020 ($ millions)
Exhibit 12: Clinical microbiology metrics analysis
Exhibit 13: Market overview of POCT instruments
Exhibit 14: Market share for POCT testing in the US 2015
Exhibit 15: Global POCT instruments market 2015-2020 ($ billions)
Exhibit 16: POCT metrics analysis
Exhibit 17: Market overview of SMBG instruments
Exhibit 18: Global SMBG instruments market 2015-2020 ($ billions)
Exhibit 19: SMBG metrics analysis
Exhibit 20: Market overview of tissue diagnostics instruments
Exhibit 21: Global tissue diagnostic instruments market 2015-2020 ($ billions)
Exhibit 22: Tissue diagnostics metrics analysis
Exhibit 23: Market overview of molecular diagnostics instruments
Exhibit 24: Global molecular diagnostic instruments market 2015-2020 ($ billions)
Exhibit 25: Molecular diagnostics metrics analysis
Exhibit 26: Market overview of hematology instruments
Exhibit 27: Global hematology instruments market 2015-2020 ($ millions)
Exhibit 28: Hematology metrics analysis
Exhibit 29: Global hematology instruments market 2015-2020 ($ millions)
Exhibit 30: Global hemostasis instruments market 2015-2020 ($ millions)
Exhibit 31: Hemostasis metrics analysis
Exhibit 32: Global IVD instruments: Segmentation by end-users
Exhibit 33: Global IVD instruments market segmentation by end-user 2015
Exhibit 34: Various types of reference measurement services
Exhibit 35: Global clinical reference laboratory services market by service provider
Exhibit 36: Global clinical reference laboratory services market share by service provider 2015 and 2020 (%)
Exhibit 37: Various types of home care
Exhibit 38: Geographic segmentation of global IVD market 2015-2020 (%)
Exhibit 39: Geographic segmentation of global IVD market 2015-2020 ($ billions)
Exhibit 40: IVD instruments market overview in Americas 2015
Exhibit 41: IVD instruments market in Americas 2015-2020 ($ billions)
Exhibit 42: IVD instruments market overview in EMEA 2015
Exhibit 43: IVD instruments market in EMEA 2015-2020 ($ billions)
Exhibit 44: IVD instruments market overview in APAC 2015
Exhibit 45: IVD instruments market in APAC 2015-2020 ($ billions)
Exhibit 46: Drivers for emerging markets
Exhibit 47: Challenges for emerging markets
Exhibit 48: Strategic initiatives for market growth
Exhibit 49: Impact of drivers
Exhibit 50: Impact of drivers and challenges
Exhibit 51: Leasing of IVD instruments
Exhibit 52: Recent M&A in the market
Exhibit 53: Companies with joint venture agreement
Exhibit 54: Competitive structure analysis of global IVD instruments market 2015
Exhibit 55: Global IVD instruments market: Competitive landscape 2015
Exhibit 56: Abbott Laboratories: Strength assessment
Exhibit 57: Abbott Laboratories: Strategy assessment
Exhibit 58: Abbott Laboratories: Opportunity assessment
Exhibit 59: Danaher: Strength assessment
Exhibit 60: Danaher: Strategy assessment
Exhibit 61: Danaher: Opportunity assessment
Exhibit 62: Roche Diagnostics: Strength assessment
Exhibit 63: Roche Diagnostics: Strategy assessment
Exhibit 64: Roche Diagnostics: Opportunity assessment
Exhibit 65: Siemens Healthcare: Strength assessment
Exhibit 66: Siemens Healthcare: Strategy assessment
Exhibit 67: Siemens Healthcare: Opportunity assessment
Exhibit 68: Thermo Fisher Scientific: Strength assessment
Exhibit 69: Thermo Fisher Scientific: Strategy assessment
Exhibit 70: Thermo Fisher Scientific: Opportunity assessment
Exhibit 71: Alere company analysis
Exhibit 72: Becton Dickinson company analysis
Exhibit 73: bioMérieux company analysis
Exhibit 74: Sysmex company analysis
Exhibit 75: Key news

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT